125 related articles for article (PubMed ID: 3881263)
1. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vzquez A; Dominguez R; Fraiman H; Vila J; Benjamin V; Matera V
Acta Neurol Scand Suppl; 1989; 127():31-5. PubMed ID: 2631519
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
Herskovits E; Vazquez A; Famulari A; Smud R; Tamaroff L; Fraiman H; Gonzalez AM; Vila J; Matera V
Lancet; 1981 May; 1(8227):966-8. PubMed ID: 6112386
[TBL] [Abstract][Full Text] [Related]
5. Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Lucas MA
Angiology; 1984 Jul; 35(7):443-50. PubMed ID: 6465619
[TBL] [Abstract][Full Text] [Related]
6. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
8. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
Apollonio A; Castignani P; Magrini L; Angeletti R
J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
Li X; Zhou G; Zhou X; Zhou S
J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
[TBL] [Abstract][Full Text] [Related]
11. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
[TBL] [Abstract][Full Text] [Related]
12. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
De Martiis M; Parenzi A; Barlattani A; De Martiis A
Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
[No Abstract] [Full Text] [Related]
15. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
Schwab S
MMW Fortschr Med; 2009 Jul; 151(30-33):60-1. PubMed ID: 19722467
[No Abstract] [Full Text] [Related]
17. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
Verro P; Gorelick PB; Nguyen D
Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
[TBL] [Abstract][Full Text] [Related]
18. European Stroke Prevention Study. ESPS Group.
Stroke; 1990 Aug; 21(8):1122-30. PubMed ID: 2202093
[TBL] [Abstract][Full Text] [Related]
19. Hemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline--a prospective study.
Ott E; Körner E; Lechner H
Angiology; 1988 Jun; 39(6):520-5. PubMed ID: 3377272
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline for prevention of transient ischaemic attacks.
Gawel MJ; Steiner TJ; Rose FC
Lancet; 1981 Jun; 1(8232):1266. PubMed ID: 6112592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
